Mark Boguniewicz
#156,146
Most Influential Person Now
Researcher
Mark Boguniewicz's AcademicInfluence.com Rankings
Mark Boguniewiczcomputer-science Degrees
Computer Science
#8605
World Rank
#9046
Historical Rank
Computational Linguistics
#1949
World Rank
#1970
Historical Rank
Machine Learning
#3567
World Rank
#3611
Historical Rank
Artificial Intelligence
#3876
World Rank
#3932
Historical Rank
Download Badge
Computer Science
Mark Boguniewicz's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Mark Boguniewicz Influential?
(Suggest an Edit or Addition)Mark Boguniewicz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Endogenous antimicrobial peptides and skin infections in atopic dermatitis. (2002) (1839)
- New insights into atopic dermatitis. (2004) (1383)
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulation (2011) (884)
- Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. (1994) (779)
- Cytokine modulation of atopic dermatitis filaggrin skin expression. (2007) (743)
- Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 (2003) (732)
- Tight junction defects in patients with atopic dermatitis. (2011) (571)
- Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. (2006) (469)
- Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report (2006) (434)
- In vivo expression of IL-12 and IL-13 in atopic dermatitis. (1996) (381)
- Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. (2016) (371)
- Atopic dermatitis: a practice parameter update 2012. (2013) (366)
- Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. (2008) (360)
- Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. (2002) (334)
- Recent insights into atopic dermatitis and implications for management of infectious complications. (2010) (321)
- Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. (2003) (321)
- Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. (2006) (319)
- Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. (2003) (309)
- IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. (2006) (303)
- Cytokine modulation of atopic dermatitis filaggrin skin expression. (2009) (301)
- A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. (1998) (298)
- Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. (1991) (285)
- Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. (2018) (281)
- Cathelicidin deficiency predisposes to eczema herpeticum. (2006) (256)
- Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. (2001) (242)
- Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. (2004) (239)
- Cost of atopic dermatitis and eczema in the United States. (2001) (234)
- Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. (2009) (232)
- Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. (2009) (211)
- Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. (2019) (200)
- Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. (2005) (198)
- Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis (2019) (197)
- Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. (2008) (192)
- Mechanism of HBD-3 deficiency in atopic dermatitis. (2006) (183)
- Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape. (2018) (173)
- Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. (2010) (163)
- TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier. (2011) (155)
- Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines (2017) (148)
- Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. (1990) (144)
- The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. (2007) (142)
- Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. (1995) (139)
- Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial. (2020) (135)
- Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. (2008) (133)
- Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response. (2011) (126)
- Evaluation of food allergy in patients with atopic dermatitis. (2013) (124)
- Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies. (2017) (121)
- 10. Atopic dermatitis. (2006) (121)
- Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders (2018) (119)
- The effects of nebulized recombinant interferon-γ in asthmatic airways (1995) (119)
- A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. (2004) (113)
- Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. (2005) (113)
- Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial (2015) (112)
- Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. (2000) (108)
- Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype. (2018) (107)
- Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults (2019) (106)
- Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. (2001) (100)
- Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. (1998) (98)
- Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions” (2019) (94)
- Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults. (2018) (89)
- Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. (2011) (89)
- A randomized controlled double‐blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis (2014) (88)
- Study of the Atopic March: Development of Atopic Comorbidities (2016) (88)
- History of eczema herpeticum is associated with the inability to induce human β‐defensin (HBD)‐2, HBD‐3 and cathelicidin in the skin of patients with atopic dermatitis (2010) (80)
- A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. (2006) (78)
- Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care Providers (2015) (76)
- Current management of atopic dermatitis and interruption of the atopic march. (2003) (75)
- Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants (2015) (74)
- Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled Study (2005) (73)
- Loricrin and Involucrin Expression is Down-Regulated by Th2 Cytokines through STAT-6 (2008) (72)
- Pain is a common and burdensome symptom of atopic dermatitis in United States adults. (2019) (68)
- A multidisciplinary approach to evaluation and treatment of atopic dermatitis. (2008) (67)
- A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus Opinion (2016) (65)
- Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis. (2003) (64)
- Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program. (2014) (58)
- Genetic Variants in Interferon Regulatory Factor 2 (IRF2) are Associated with Atopic Dermatitis and Eczema Herpeticum (2011) (57)
- Food Allergy in Infants With Atopic Dermatitis: Limitations of Food-Specific IgE Measurements (2015) (57)
- The effects of inhaled interferon gamma in normal human airways. (1993) (55)
- Treatment of steroid‐dependent asthma with recombinant interferon‐gamma (1993) (54)
- Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis (2017) (54)
- In vivo expression of cytokine receptor mRNA in atopic dermatitis. (1998) (53)
- Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus. (2007) (49)
- MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. (2008) (49)
- TNF-alpha Down-Regulates Filaggrin and Loricrin Through c-Jun N-Terminal Kinase: Role for TNF Antagonists to Improve Skin Barrier (2011) (48)
- The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections. (2011) (46)
- Current perspectives on latex allergy. (1996) (46)
- Health Utility Scores of Atopic Dermatitis in US Adults. (2019) (45)
- Beryllium Skin Patch Testing to Analyze T Cell Stimulation and Granulomatous Inflammation in the Lung1 (2002) (45)
- Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial (2019) (43)
- The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition (2018) (42)
- Hypersensitivity reactions to antibiotics commonly used in children (1995) (41)
- Decreased IL-15 May Contribute to Elevated IgE and Acute Inflammation in Atopic Dermatitis1 (2002) (40)
- Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis. (2005) (39)
- Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines. (2017) (38)
- Legionella and Pneumocystis pneumonias in asthmatic children on high doses of systemic steroids (1994) (37)
- Distribution of atopic dermatitis lesions in United States adults (2019) (37)
- The effects of nebulized recombinant interferon-gamma in asthmatic airways. (1995) (37)
- The autoimmune nature of chronic urticaria. (2008) (36)
- Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis. (2018) (35)
- Atopic dermatitis: beyond the itch that rashes. (2005) (35)
- Atopic Dermatitis in US Adults: From Population to Health Care Utilization. (2019) (34)
- Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults. (2018) (34)
- An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature. (2010) (33)
- Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis (2019) (33)
- Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United States. (2013) (33)
- Sustained Efficacy and Safety of Pimecrolimus Cream 1% when Used Long‐term (up to 26 Weeks) to Treat Children with Atopic Dermatitis (2008) (33)
- Effect of cat and daycare exposures on the risk of asthma in children with atopic dermatitis (2012) (30)
- Severe refractory atopic dermatitis in adults is highly atopic. (2007) (30)
- Vaccinia virus-specific molecular signature in atopic dermatitis skin. (2011) (28)
- The infectious complications of atopic dermatitis (2020) (27)
- New visions for atopic eczema: An iPAC summary and future trends (2008) (27)
- A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis. (2007) (26)
- Pathophysiologic mechanisms in atopic dermatitis. (2001) (26)
- The ABC's of managing patients with severe atopic dermatitis. (2013) (25)
- Strategies for Successful Management of Severe Atopic Dermatitis. (2019) (25)
- Validation of five patient‐reported outcomes for atopic dermatitis severity in adults (2019) (24)
- New concepts in atopic dermatitis. (1996) (23)
- Disease management of atopic dermatitis (2004) (23)
- Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials (2021) (22)
- A comparison of five ways to measure atopic dermatitis severity in adults (2020) (22)
- Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls. (2010) (20)
- Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in Adults. (2019) (20)
- Comparisons of efficacy and cost-effectiveness of topical immunomodulators in the management of atopic dermatitis (2003) (20)
- Topical treatment of atopic dermatitis. (2004) (19)
- Advances in allergic skin diseases. (2003) (19)
- Wet Wrap Therapy in Moderate to Severe Atopic Dermatitis. (2017) (19)
- Addition of topical pimecrolimus to once‐daily mid‐potent steroid confers no short‐term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial (2007) (19)
- Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families (2018) (19)
- Patient‐reported outcomes from a multicenter, randomized, vehicle‐controlled clinical study of MAS063DP (Atopiclair™) in the management of mild‐to‐moderate atopic dermatitis in adults (2008) (18)
- Atopic dermatitis: a question of balance. (1998) (17)
- Adverse Reactions to Antibiotics (1995) (17)
- Successful strategies in atopic dermatitis management. (2008) (17)
- Update on atopic dermatitis: insights into pathogenesis and new treatment paradigms. (2004) (17)
- Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon‐γ‐producing CD8+ T cells (2013) (16)
- Conventional therapy for atopic dermatitis (2002) (16)
- Atopic dermatitis. (2006) (16)
- Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis. (2021) (15)
- Chronic urticaria in children. (2005) (15)
- Atopic dermatitis: the updated practice parameter and beyond. (2014) (14)
- Advances in the understanding and treatment of atopic dermatitis. (1997) (14)
- Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry (2018) (14)
- Laparoscopic fundoplication to enhance pulmonary function in children with severe reactive airway disease and gastroesopheagal reflux disease (1997) (14)
- Validation and interpretation of short form 12 and comparison with dermatology life quality index in atopic dermatitis in adults. (2019) (12)
- Targeted therapy for allergic diseases: at the intersection of cutting-edge science and clinical practice. (2015) (12)
- Economic Burden of Atopic Dermatitis in High-Risk Infants Receiving Cow's Milk or Partially Hydrolyzed 100% Whey-Based Formula. (2015) (11)
- Role of the thymus in natural tolerance to an autologous protein antigen (1989) (10)
- New strategies for dealing with Staphylococcus aureus colonization and the emerging methicillin-resistant Staphylococcus aureus epidemic in atopic dermatitis. (2012) (10)
- The Allergic Profile Of Infants In The SAM Study: A Large Longitudinal Study Of Development Of Asthma And Allergies In Patients With Atopic Dermatitis (2007) (10)
- Cytokine Modulation of AD Filaggrin Skin Expression (2009) (10)
- Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial (2021) (10)
- 963 In vivo expression of interleukin-12 and interleukin-13 in atopic dermatitis (1996) (9)
- Epidemiology and Burden of Sleep Disturbances in Atopic Dermatitis in US Adults (2021) (8)
- Abnormal Immune Response to Varicella Vaccine in Subjects with Atopic Dermatitis Compared to Non-atopic controls (2008) (8)
- Biologics for Atopic Dermatitis. (2020) (8)
- Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology. (2004) (8)
- 383 Recombinant interferon-gamma (rIFN-γ) therapy reduces the clinical severity of atopic dermatitis (AD) (1991) (8)
- Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-analysis. (2022) (7)
- Reductions in Claudin-1 May Enhance Susceptibility to HSV-1 Infections in Atopic Dermatitis (2011) (7)
- Management of the patient with allergic reactions to antibiotics (1992) (7)
- Allergic Diseases, Quality of Life, and the Role of the Dietitian (2008) (7)
- The economics of topical immunomodulators for the treatment of atopic dermatitis (2012) (7)
- Modulation of Filaggrin by Th2 Cytokines in the Skin of Atopic Dermatitis (AD) (2007) (7)
- Bleach baths for atopic dermatitis: a systematic review and meta-analysis. (2022) (7)
- Current guidelines for the evaluation and management of atopic dermatitis – A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology Guidelines (2017) (7)
- 382 In vivo IFN-γ treatment normalizes diminished IL4 response of mononuclear cells(MNC) in atopic dermatitis(AD) (1991) (7)
- Atopic dermatitis. (2008) (7)
- Investigational and unproven therapies in atopic dermatitis. (2010) (7)
- Understanding and treating atopic dermatitis. (1999) (6)
- Atopic Dermatitis and Contact Dermatitis in the Emergency Department (2007) (5)
- Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis (2021) (5)
- Genetic Variants in TSLP and its Receptor, IL7R, Contribute to an Increased Risk for Atopic Dermatitis and Eczema Herpeticum in Two American Populations (2009) (5)
- Atopic dermatitis Subjects Colonized with Staphylococcus aureus have a Distinct Phenotype and Endotype (2018) (5)
- 1% pimecrolimus cream for atopic dermatitis. (2003) (5)
- Human Atopic Dermatitis Complicated by Eczema Herpeticum is Associated with Abnormalities in Gamma Interferon Response (2011) (4)
- Atopy, airway responsiveness, and genes. (1996) (4)
- Elevated levels of IL-10 in intrinsic (IAD) and extrinsic atopic dermatitis (EAD) is associated with deficiency in anti-microbial peptide (AMP) production (2004) (4)
- General management of patients withatopic dermatitis (2008) (4)
- Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis (2022) (4)
- crisaborole topical ointment, 2%: A novel, nonsteroidal, topical antiinflammatory, phosphodiesterase 4 inhibitor: Results from two phase 3 studies treating children and adult patients with mild to moderate atopic dermatitis : 3519 (2016) (4)
- Reduced expression of human β defensin-2 (HBD-2) and CCR6 in atopic dermatitis (AD) (2002) (4)
- Variations in the CCL20 and CCR6 Genes are Associated with Atopic Dermatitis and Eczema Herpeticum in Populations of European and African descent. (2009) (4)
- Combination therapy and new directions for managing atopic dermatitis. (2002) (4)
- Variants in the Tight Junction Gene, Claudin-1 are Associated with Atopic Dermatitis in Two American Populations and May Contribute to Skin Barrier Dysfunction (2009) (4)
- Biomarkers of Disease Severity and Th2 Polarity are Predictors of Risk for Eczema Herpeticum (2008) (4)
- Efficacy and Safety of Crisaborole Topical Ointment, 2%, a Novel, Nonsteroidal, Topical, Anti-Inflammatory, Phosphodiesterase Inhibitor in 2 Phase 3 Studies in Children and Adults with Mild-to-Moderate Atopic Dermatitis (2016) (4)
- Dupilumab Improves Outcomes of Concurrent Asthma and Chronic Sino‐Nasal Conditions in Patients With Atopic Dermatitis—a Pooled Analysis of Four Phase 3 Studies (LIBERTY AD SOLO 1 & 2, CHRONOS, and CAFÉ): 370 (2019) (4)
- Treatment options and new therapeutic approaches in atopic dermatitis. (2003) (3)
- Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis (2022) (3)
- Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16 (2021) (3)
- Collaboration in best practices for care of patients with atopic dermatitis. (2016) (3)
- Ciclesonide, administered once daily, has a low incidence of oropharyngeal adverse events in pediatric asthma patients (2005) (3)
- Conventional Topical Treatment of Atopic Dermatitis (2002) (3)
- Iconographies supplémentaires de l'article : Tight junction defects in patients with atopic dermatitis (2011) (3)
- 26887 Effect of ruxolitinib cream on sleep disturbance and sleep impairment: Pooled analysis from two randomized phase 3 studies (2021) (3)
- Interferon-gamma (IFNG) and IFNGR1 Gene Variants are Associated with Atopic Dermatitis Complicated by Eczema Herpeticum (ADEH) and IFN Production (2011) (2)
- Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczema (2012) (2)
- Genetic Variants In Interferon Regulatory Factor 2 (irf2) Are Associated With Atopic Dermatitis And Eczema Herpeticum In Populations Of European And African Descent (2010) (2)
- Atopic Dermatitis and Allergic Contact Dermatitis (2022) (2)
- Allergen Immunotherapy for Atopic Dermatitis: A Systematic Review and Meta-Analysis of Benefits and Harms. (2022) (2)
- Adverse Reactions to Drugs (2011) (2)
- O063 Crisaborole demonstrates improvement in quality of life in patients with mild to moderate atopic dermatitis (2016) (2)
- Deficient HBD-3 in the Skin of Atopic Dermatitis (AD) Patients Increases Susceptibility to Recurrent Viral Skin Infections (2006) (2)
- 51 – Management of Atopic Dermatitis (2016) (2)
- Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice (2019) (2)
- Effect of Dupilumab on the Host-Microbe Interface in Atopic Dermatitis (2022) (1)
- New Treatment Modalities (2014) (1)
- Two phase 3 studies in atopic dermatitis with crisaborole, the novel, nonsteroidal topical phosphodiesterase 4 inhibitor (2016) (1)
- Mental health in adult AD (2019) (1)
- Long-term safety of topically applied tacrolimus ointment in adult atopic dermatitis patients (2002) (1)
- Glucocorticoid-Induced TNF-Receptor Related Ligand (GITR-L) is Increased in Atopic Dermatitis (AD) Skin (2006) (1)
- Tacrolimus ointment 0.03 is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric and adult patients (2004) (1)
- Exome Chip Genotyping Reveals Association with LAMA3 (laminin, alpha 3) Gene and Eczema Herpeticum in a Population of European Descent (2013) (1)
- Measurement properties of Hospital Anxiety and Depression Scale used in atopic dermatitis in adults: 391 (2019) (1)
- Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis. (2022) (1)
- Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema): A Systematic Review. (2022) (1)
- Abnormal Immune Responses to Herpes Simplex in Subjects with Atopic Dermatitis Complicated by Eczema Herpeticum (2009) (1)
- CHAPTER 56 – Contact Dermatitis (2010) (1)
- Efficacy of Abrocitinib Rescue Therapy in the Phase 3 Study JADE REGIMEN (2022) (1)
- Skin Lipid Composition Varies Based on Clinical Subphenotypes in Adult European American Atopic Dermatitis Subjects (2016) (1)
- 101 Dupilumab Improves Outcomes of Concurrent Asthma and Chronic Sino-Nasal Conditions in Patients With Atopic Dermatitis—a Pooled Analysis of Four Phase 3 Studies (LIBERTY AD SOLO 1 & 2, CHRONOS, and CAFÉ) (2019) (1)
- 282 Moderate to severe atopic dermatitis is associated with allergic, autoimmune and cardiovascular comorbidities in US adults (2018) (1)
- Treatment, resources, and impact of atopic dermatitis-the triad study 1 1 Authors have received comp (2004) (1)
- Conjugates or dsDNA Linked to Human Gammaglobulin Inhibit Anti-dsDNA Antibodies In Vitro (1994) (0)
- 408 Dupilumab reduces biomarkers indicative of type 2 inflammation in children aged ≥ 6 months to 5 years with moderate-to-severe atopic dermatitis (2022) (0)
- ES8 Treatment strategies for atopic dermatitis : the role of topical calcineurin inhibitors (2014) (0)
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials (2022) (0)
- IL5 Atopic dermatitis : new insights and therapeutic implications (2014) (0)
- 234 Atopic dermatitis is associated with distinct phenotypes in US adults (2019) (0)
- 321 Cancer risk with topical pimecrolimus and tacrolimus for atopic dermatitis: systematic review and Bayesian meta-analysis (2023) (0)
- 248 Patient and physician perspectives in atopic dermatitis: a population-based cross-sectional study (2019) (0)
- Interaction Between the R501X Filaggrin Mutation and Disease Severity Associates with Increased Staphylococcus Aureus Colonization in European American Subjects with Atopic Dermatitis (2016) (0)
- 519 Rapid reduction in S. aureus & cytotoxins in dupilumab treated atopic dermatitis subjects (2022) (0)
- My Patient Is Not Eligible for Biologics: Current Non-Biologic Therapies for Atopic Dermatitis (2019) (0)
- The year book of allergy, asthma and clinical immunology (1999) (0)
- Identification of Differences in the Molecular Response to Vaccinia Virus in Atopic Dermatitis and Psoriasis Skin (2009) (0)
- BREATHING CESSATION IN CHILD WITH ASTHMA AND INDUCIBLE LARYNGEAL OBSTRUCTION: WHEN TWO DIAGNOSES AREN'T ENOUGH (2018) (0)
- Differences in gene expression array of superantigen-stimulated PBMC from patients with atopic dermatitis (AD) vs normal subjects (2002) (0)
- Inflammation in the Lung Cell Stimulation and Granulomatous Beryllium Skin Patch Testing to Analyze T (2002) (0)
- Distinct Features Identified in Adult Atopic Dermatitis Subjects Based on Age of Onset (2016) (0)
- 666 Effect of dupilumab on the host-microbe interface in atopic dermatitis (2021) (0)
- ABSTRACTS | Epidermal Structure & Barrier Function (2015) (0)
- Tumor Necrosis Factor (TNF)-alpha Down-Regulates Loricrin and Involucrin (2010) (0)
- Comprar Atopic Dermatitis, An Issue Of Immunology And Allergy Clinics | M. Boguniewicz | 9781437724585 | Saunders (2010) (0)
- Atopic Dermatitis: Bench to Bedside and Back (2019) (0)
- 297 Dupilumab reduces biomarkers indicative of type 2 inflammation in children aged ≥ 6 months to < 6 years with moderate-to-severe atopic dermatitis (2022) (0)
- 53 – Contact Dermatitis (2016) (0)
- Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin. (2023) (0)
- 189 Microbial expression of lantibiotics may explain discrepancies between S. aureus culturability and metagenomics in atopic dermatitis subjects and healthy controls (2021) (0)
- Nonlesional Atopic Dermatitis Skin Shows Alterations in Langerhans Cells in Close Proximity to Tight Junction Fragmentation: 918 (2019) (0)
- 367 Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis (2022) (0)
- Phase 3 Studies Treating Children and Adult Patients with Mild to Moderate Atopic Dermatitis with Crisaborole Ointment, a Novel, Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor (2018) (0)
- Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials (2018) (0)
- 507 Evidence of tissue remodelling in skin of patients with atopic dermatitis (2000) (0)
- TH-17-Associated Cytokines in Atopic Dermatitis (2009) (0)
- Anti-Viral Effects of C-C Chemokine Macrophage Inflammatory Peptide 3 Alpha (MIP-3α) (2006) (0)
- Sequencing Of The Flg2 Gene In Patients With Atopic Dermatitis And Eczema Herpeticum In A Population Of European Descent. (2012) (0)
- Th2 Cytokines Act on S100/A11 to Down-regulate Keratinocyte Differentiation: Implications for Atopic Dermatitis (2008) (0)
- Staphylococcus Aureus -Culture Positivity Observed In Adults With Atopic Dermatitis Is Most Indicative Of An Increased Absolute and Relative Abundance Of S. Aureus and Not Reduced Biodiversity (2018) (0)
- Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life (2022) (0)
- 34 – Atopic Dermatitis (2014) (0)
- 317 S. aureus colonization is associated with impaired skin barrier function and greater Th2 activation in adult subjects with AD (2016) (0)
- 27406 Dupilumab improves signs and symptoms of severe atopic dermatitis in children aged 6–11 years with and without comorbid asthma (2021) (0)
- Dupilumab Treatment Reduces Total IgE Levels in Patients 6 Months and Older with Moderate-to-Severe Atopic Dermatitis (2023) (0)
- Depth and Rapidity of Response With Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis (AD) in JADE COMPARE (2021) (0)
- Safety and efficacy of open-label dupilumab in adult patients with atopic dermatitis: An interim analysis at week 76 (2019) (0)
- Dupilumab Reduces Inflammatory Biomarkers in Patients Aged 6 Months to 18 Years With Moderate-to-Severe or Severe Atopic Dermatitis (2023) (0)
- The Child with Recalcitrant Atopic Dermatitis (2013) (0)
- Immunological Analysis of the Atopic March (AM) (2009) (0)
- The Association Between HLA B7 Alleles and Human Atopic Dermatitis Complicated by Eczema Herpeticum (2012) (0)
- Immunologic Phenotype in the Atopic March (AM) (2007) (0)
- 1624 Phenotypic and endotypic determinants of atopic dermatitis severity from the ADRN registry (2023) (0)
- Atopic Dermatitis Yardstick Update. (2023) (0)
- Suppression of innate immune response genes in the skin of atopic dermatitis (AD) (2003) (0)
- Management of Children and Adult Patients with Atopic Dermatitis (2013) (0)
- 32824 Factors associated with treatment satisfaction in atopic dermatitis: A cross-sectional, population-based study examining patient and physician perspectives (2022) (0)
- 1599 Rapid reduction in S. aureus in atopic dermatitis subjects following dupilumab treatment (2023) (0)
- 546 Pain is a distinct and burdensome symptom of atopic dermatitis in US adults (2019) (0)
- Scientific Abstract Sessions (2006) (0)
- 245 Validation and interpretation of short form 12 and comparison with dermatology life quality index in adult atopic dermatitis (2019) (0)
- Conjunctivitis in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial (2022) (0)
- 384 Dupilumab provides early and sustained, clinically-meaningful improvements in both adults and adolescents: A post hoc analysis of patients not achieving Investigator’s Global Assessment of 0/1 in phase 3 trials, LIBERTY AD SOLO 1 and 2, and LIBERTY AD ADOL (2020) (0)
- Atopic Dermatitis (AD) and Eczema Herpeticum (EH): Role of Cathelicidins in Herpes Simplex Virus (HSV) Infection (2006) (0)
- Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long‐term efficacy and patient‐reported outcomes (2022) (0)
- New Biological Therapies on the Horizon for Allergic Skin Diseases (2016) (0)
- Induction of Innate Immune Response Genes Compared to Psoriasis , Skin Prevents Cytokine Milieu of Atopic Dermatitis (2003) (0)
- CLA+T Cells Play an Important Role in the Atopic March (AM) (2008) (0)
- 27050 Efficacy of baricitinib 2-mg stratified by baseline body surface area in adults with moderate-to-severe atopic dermatitis (2021) (0)
- Free Communications 1 : Debate and Comments with the Expert Chairs CO 01 TOPICAL CORTICOSTEROID PHOBIA IN ATOPIC DERMATITIS : AN INTERNATIONAL VALIDATIONSTUDYOF THE TOPICOP SCORE (2016) (0)
- New Directions for the Prevention and Treatment of Atopic Dermatitis (2017) (0)
- Exome Chip Genotyping Reveals Association With PDE4C and Atopic Dermatitis In Populations Of European and African Descent (2014) (0)
- Efficacy of Baricitinib in Patients with Atopic Dermatitis and Atopic Comorbidities: Results of Pooled Data from 2 Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-week Trials (BREEZE-AD1 and BREEZE-AD2) (2020) (0)
- Severe Refractory Atopic Dermatitis (AD) in Adult Patients, as Compared to Quiescent and Moderate AD is Highly Atopic (2007) (0)
- CHAPTER 54 – Management of Atopic Dermatitis (2010) (0)
- Dupilumab Improves Signs And Symptoms Of Severe Atopic Dermatitis In Children Aged 6–11 Years With And Without Comorbid Asthma (2021) (0)
- Variations In The FLG2 Gene Are Associated With Eczema Herpeticum In Populations Of European And African Descent (2011) (0)
- Study of Adult Atopic Dermatitis and Comorbidities in the US Department of Defense Healthcare System (2020) (0)
- Association of Gene Variant in IL12B Gene with Atopic Dermatitis Complicated by Eczema Herpeticum (ADEH) (2012) (0)
- Patients with adult- and late childhood-onset atopic dermatitis report a higher burden of disease severity than patients with early childhood-onset atopic dermatitis. (2018) (0)
- Dupilumab Efficacy in Children With Atopic Dermatitis Aged 6 Months to 5 Years With and Without Atopic Comorbidities (2023) (0)
- Th2 cytokines down-regulate cathelicidin expression and increases atopic dermatitis (AD) skin susceptibility to viral infection (2005) (0)
- Atopic Dermatitis Associated with Eczema Herpeticum is Associated with Abnormal Expression of Keratin Genes in Skin Biopsies (2011) (0)
- Atopic and Contact Dermatitis (2019) (0)
- List of Contributors (2019) (0)
- Two phase 3 study results of children and adults with mild-to-moderate atopic dermatitis treated with Crisaborole Topical Ointment, 2%, a novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase 4 inhibitor (2016) (0)
- Biomarkers of Disease Severity and Th2 Polarity Are Predictors of Atopic Dermatitis Subjects Who Are Colonized with S. Aureus (2013) (0)
- Filaggrin R501X Mutation is Associated with an Increased Susceptibility to Atopic Dermatitis and Eczema Herpeticum, and Associated Phenotypes in a European Population (2009) (0)
- Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis (2023) (0)
- Efficacy of Lebrikizumab in Patients With Atopic Dermatitis and Atopic Comorbidities: Pooled Results From Two Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-Week Studies (ADvocate1 and ADvocate2) (2023) (0)
- Differential Gene Expression in Persistent as Compared to Resolved Atopic Dermatitis (2010) (0)
- Total and Specific IgE are elevated in Atopic March (AM) (2008) (0)
- Effect of Abrocitinib and Dupilumab on Eosinophil Levels in Patients With Moderate-to-Severe Atopic Dermatitis and With or Without Comorbid Asthma or Allergic Rhinitis: A Post Hoc Pooled Analysis of JADE COMPARE and JADE DARE (2023) (0)
- Increased Risk of Eczema Vaccinatum in Atopic Dermatitis Patients with a History of Herpetic Infections (2010) (0)
- Are skin microbes with lantibiotic biosynthesis genes reduced in atopic dermatitis subjects who are culture positive for Staphylococcus aureus? (2022) (0)
- 188 Predictors of healthcare utilization in US adults with atopic dermatitis (2019) (0)
- Indications for the Use of Biologics and Applications in Practice (2018) (0)
- Practice parameter Atopic dermatitis : A practice parameter update 2012 (2013) (0)
- Efficacy of Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis With and Without Comorbid Asthma: Subgroup Analysis From a Phase 3 Trial (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mark Boguniewicz?
Mark Boguniewicz is affiliated with the following schools:
